Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
David van Duin, MD, PhD, FIDSA, FAST. Professor in the Infectious Diseases Division at the University of North Carolina. Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are infections caused by multi-drug resistant Gram-negative bacteria, especially carbapenem-resistant Enterobacterales, and infections in immunocompromised patients.
Disclosure(s): Entasis: Advisor/Consultant (Terminated, August 24, 2021), Honoraria (Terminated, August 24, 2021); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); pfizer: Honoraria (Terminated, March 17, 2022); Qpex: Advisor/Consultant (Terminated, February 18, 2023); Roche: Advisor/Consultant (Ongoing); Shionogi: Advisor/Consultant (Terminated, February 16, 2023), Grant/Research Support (Terminated, February 16, 2023)
Thursday, October 12, 2023
3:15 PM – 3:27 PM US ET
175 - C. diff, C. auris, MDROs, Oh My
Friday, October 13, 2023
1:45 PM – 3:00 PM US ET
210 - Effects of Antibiotics on Bacterial Virulence
Saturday, October 14, 2023
10:30 AM – 11:45 AM US ET
2045 - Confluence of Resistance and Virulence in Klebsiella pneumoniae
Saturday, October 14, 2023
10:55 AM – 11:20 AM US ET